/ News, Research
Cell therapy meets the very latest in gene editing: start-up Cimeio joins forces with Prime Medicine (Jeker Lab)
Gentler cell therapies for blood cancer and other serious blood diseases – this is the goal that Cimeio Therapeutics, a University of Basel spin-off, has set itself. The start-up has been able to make a great step forward together with a…